⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7346771 | 0.79 | CD44 (0.42) | — | |
| SCHEMBL8384 | 0.78 | TSHR (0.35) | — | |
| SCHEMBL10885088 | 0.77 | CYP3A4 (0.36) | — | |
| SCHEMBL7146499 | 0.77 | NPC1 (0.67) | — | |
| SCHEMBL1922269 | 0.77 | CYP3A4 (0.76) | — | |
| SCHEMBL3289851 | 0.75 | MMP2 (0.47) | — | |
| SCHEMBL7332288 | 0.75 | CYP3A4 (0.56) | — | |
| SCHEMBL9099850 | 0.75 | ALDH1A1 (0.59) | — | |
| SCHEMBL16099809 | 0.74 | MAPT (0.55) | — | |
| SCHEMBL157540 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2342 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118215676-A | Specific conjugation of antibody drug conjugates | 杭州多禧生物科技有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-117980327-A | Specific coupling of antibodies | 杭州多禧生物科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| WO-2024074585-A2 | MICROPARTICLE AND IMPLANT FORMULATIONS FOR cGMP ANALOG THERAPY | MIRECA MEDICINES GMBH (DE) | 2024-04-11 | — | — | WO | claimed |
| WO-2024040075-A1 | EXTRACELLULAR VESICLE COMPRISING A BIOLOGICALLY ACTIVE MOLECULE AND A DUAL CLEAVABLE LINKER | LONZA SALES AG (CH) | 2024-02-22 | — | — | WO | claimed |
| US-11851697-B2 | Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment | GLYMPSE BIO, INC. (US) | 2023-12-26 | — | — | US | claimed |
| EP-4267628-A1 | ANTIBODIES SPECIFIC FOR STRUCTURALLY DISORDERED SEQUENCES | XL-protein GmbH (DE) | 2023-11-01 | — | — | EP | claimed |
| CN-116854804-A | Acylated oxyntomodulin peptide analogues | 东亚ST株式会社 | 2023-10-10 | — | — | CN | claimed |
| WO-2023192417-A2 | EX VIVO PROTEASE ACTIVITY DETECTION FOR HEPATOCELLULAR CARCINOMA | GLYMPSE BIO, INC. (US) | 2023-10-05 | — | — | WO | claimed |
| WO-2023172648-A2 | FLUOROGENIC SUBSTRATES FOR AMINOPEPTIDASE DETECTION IN BIOFLUIDS | GLYMPSE BIO, INC. (US) | 2023-09-14 | — | — | WO | claimed |
| US-20230242568-A1 | POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES | MIRECA MEDICINES GMBH (DE) | 2023-08-03 | — | — | US | claimed |
| US-4314936-A | BY MEASUREM,ENT OF FLUORESENCE | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 1982-02-09 | — | — | US | claimed |
| US-4269773-A | CEPHALOSPORINS | SHIONOGI & CO., LTD. (JP) | 1981-05-26 | — | — | US | claimed |
| US-4232030-A | ANTIBIOTICS | MERCK & CO., INC. (US) | 1980-11-04 | — | — | US | claimed |
| US-4226870-A | ANTIBIOTICS, BACTERICIDES | MERCK & CO., INC. (US) | 1980-10-07 | — | — | US | claimed |
| EP-0001265-A1 | O-, N- and carboxyl derivatives of thienamycin sulfoxide and sulfone, their preparation and pharmaceuticals containing said compounds | MERCK & CO. INC. (US) | 1979-04-04 | — | — | EP | claimed |
| EP-0001264-A1 | Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation | MERCK & CO. INC. (US) | 1979-04-04 | — | — | EP | claimed |
| US-4115378-A | TEXTILES | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-19 | — | — | US | claimed |
| US-4113431-A | CELLULOSE REACTED WITH A BENZOYLATING AGENT | SHIKIBO LIMITED (JP) | 1978-09-12 | — | — | US | claimed |
| US-4002665-A | Process for substituted cyclohexenes and its products | WARNER-LAMBERT COMPANY (US) | 1977-01-11 | — | — | US | claimed |
| US-3932393-A | 3-Methylenecephalosporins and process for production thereof | ELI LILLY AND COMPANY (US) | 1976-01-13 | — | — | US | claimed |